ClinicalTrials.Veeva

Menu

Pivotal Clinical Study to Assess the Anti-adhesive Effect and Safety of ABT13107 Applied to Postoperative Intrauterine

Medytox logo

Medytox

Status

Completed

Conditions

Postoperative Adhesion of Uterus

Treatments

Device: ABT13107
Device: Hyalobarrier

Study type

Interventional

Funder types

Industry

Identifiers

NCT04007211
MT10-KR16IUA705

Details and patient eligibility

About

This study is intended to evaluate the efficacy and safety of ABT13107 compared to Hyalobarrier applied to postoperative intrauterine.

Enrollment

192 patients

Sex

Female

Ages

19 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female patients aged from 19 to 70
  • Those who are scheduled for hysteroscopy to treat the following diseases: submucosal myomas, endometrial polyps, intrauterine adhesion etc.

Exclusion criteria

  • Those who will apply other intrauterine device rather than investigational device during the study period.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

192 participants in 2 patient groups

ABT13107
Experimental group
Treatment:
Device: ABT13107
Hyalobarrier
Active Comparator group
Treatment:
Device: Hyalobarrier

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems